4 completed, 2 suspended. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Suspended 2 |
| Phase 3 | 1 | Suspended 1 |
Follow Kibow Pharma: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rollover Extension Clinical Trial To Evaluate The Long-Term Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With CKD IV Completing The US-APR2020-01 Study KT-301 (formerly US-APR2020) - Chronic Kidney Disease stage4 | Phase 2 / Phase 3 | Suspended | Kibow Pharma | 600 | 2022-04-21 | 2024-09-19 |
| Clinical Trial To Evaluate Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With Chronic Kidney Disease Stage IV US-APR2020, Placebo - Chronic Kidney Disease stage4 | Phase 2 | Suspended | Kibow Pharma | 630 | 2021-06-24 | 2024-09-19 |
| Observational Study of Kibow Biotics in Chronic Kidney Failure Patients Kibow Biotics/Renadyl - Chronic Kidney Failure | Completed | Kibow Pharma | 31 | 2011-07-01 | 2017-08-18 | |
| Observational Study of Kibow Biotics in Dialysis Patients Kibow Biotics - Chronic Kidney Failure | Completed | Kibow Pharma | 30 | 2011-05-01 | 2019-08-20 | |
| Observational Study of Kibow Biotics in Chronic Kidney Failure Patients on Dialysis Kibow Biotics - Chronic Kidney Disease | Completed | Kibow Pharma | 30 | 2011-04-01 | 2019-08-20 | |
| Pilot-Scale Clinical Trials of Kibow BioticsĀ® in Chronic Kidney Failure Chronic Kidney Failure | Completed | Kibow Pharma | 180 | 2007-08-01 | 2019-08-20 |
Kidney Failure, Chronic (3) · Renal Insufficiency, Chronic (1)
United States (6)
Stephanie DeLoach, M.D. (2) · Eli A Friedman, MD (1) · Eli Friedman, M.D., MACP, FRCP (1) · Gary Briefel, M.D. (1) · Mary Mallapallil, M.D. (1) · Subodh J Saggi, M.D., MPH (1)